OVID - Ovid Therapeutics Inc.
NASDAQ
->
Healthcare
->
Biotechnology
New York,
United States
Type: Equity
OVID price evolution
OVID
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.78 | $31.63 | $32.7 | $28.97 |
| Short term investments | $47.28 | $59.49 | $78.79 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $65.83 | $80.89 | $93.17 | $109.6 |
| Long term investments | $21.05 | $22.02 | $17.63 | |
| Property, plant & equipment | $13.59 | $13.97 | $14.31 | $14.66 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $37.2 | $38.44 | $34.43 | |
| Total investments | $68.33 | $81.51 | $96.42 | |
| Total assets | $102.65 | $118.09 | $131.61 | $144.03 |
| Current liabilities | ||||
| Accounts payable | $2.71 | $4.72 | $3.6 | $3.7 |
| Deferred revenue | ||||
| Short long term debt | $1.29 | $1.27 | $1.25 | |
| Total current liabilities | $11.63 | $14.12 | $8.9 | $11.47 |
| Long term debt | $15.07 | $44.43 | $44.76 | |
| Total noncurrent liabilities | $15.07 | $44.43 | $44.76 | |
| Total debt | $16.36 | $45.7 | $46 | |
| Total liabilities | $26.36 | $29.19 | $53.33 | $56.23 |
| Shareholders' equity | ||||
| Retained earnings | -$295.05 | -$281.04 | -$289.56 | -$277.87 |
| Other shareholder equity | $0.04 | -$0.01 | -$0.02 | $0 |
| Total shareholder equity | $88.9 | $78.28 | $87.8 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $28.97 | $2.85 | $189.73 | $72.03 |
| Short term investments | $78.79 | $84.13 | ||
| Net receivables | $0.14 | |||
| Inventory | ||||
| Total current assets | $109.6 | $131.38 | $190.48 | $74.84 |
| Long term investments | $17.63 | $5.62 | $1.63 | |
| Property, plant & equipment | $14.66 | $16.07 | $0.24 | $0.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $34.43 | $23.89 | $4.07 | $1.08 |
| Total investments | $96.42 | $89.76 | $1.63 | |
| Total assets | $144.03 | $155.27 | $194.54 | $75.93 |
| Current liabilities | ||||
| Accounts payable | $3.7 | $1.95 | $7.13 | $7.88 |
| Deferred revenue | $12.38 | |||
| Short long term debt | $1.25 | $0.53 | ||
| Total current liabilities | $11.47 | $6.99 | $14.8 | $22.06 |
| Long term debt | $44.76 | $16 | $0.06 | |
| Total noncurrent liabilities | $44.76 | $16 | $10.23 | |
| Total debt | $46 | $16.54 | ||
| Total liabilities | $56.23 | $22.99 | $14.8 | $32.29 |
| Shareholders' equity | ||||
| Retained earnings | -$277.87 | -$225.53 | -$171.36 | -$294.19 |
| Other shareholder equity | $0 | -$0.04 | $0 | |
| Total shareholder equity | $87.8 | $132.27 | $179.75 | $43.63 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.17 | $0.17 | $0.15 | $0.14 |
| Cost of revenue | ||||
| Gross Profit | $0.17 | $0.15 | $0.14 | |
| Operating activities | ||||
| Research & development | $12.58 | $10.4 | $10.64 | |
| Selling, general & administrative | $8.1 | $7.17 | $7.69 | |
| Total operating expenses | $13.4 | $20.69 | $17.57 | $18.33 |
| Operating income | -$20.52 | -$17.42 | -$18.19 | |
| Income from continuing operations | ||||
| EBIT | $8.52 | -$11.69 | -$15.32 | |
| Income tax expense | ||||
| Interest expense | -$0.78 | |||
| Net income | ||||
| Net income | -$14.01 | $8.52 | -$11.69 | -$15.32 |
| Income (for common shares) | $8.52 | -$11.69 | -$15.32 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.39 | $1.5 | $208.38 | $12.62 |
| Cost of revenue | ||||
| Gross Profit | $0.39 | $1.5 | $208.38 | $12.62 |
| Operating activities | ||||
| Research & development | $28.59 | $24.62 | $46.94 | $63.42 |
| Selling, general & administrative | $31.09 | $32.43 | $37.23 | $30.63 |
| Total operating expenses | $59.67 | $57.05 | $84.17 | $94.05 |
| Operating income | -$59.28 | -$55.55 | $124.21 | -$81.43 |
| Income from continuing operations | ||||
| EBIT | -$52.34 | -$54.17 | $124.16 | -$81.04 |
| Income tax expense | $1.33 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | -$52.34 | -$54.17 | $122.83 | -$81.04 |
| Income (for common shares) | -$52.34 | -$54.17 | $122.83 | -$81.04 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $8.52 | -$11.69 | -$15.32 | |
| Operating activities | ||||
| Depreciation | $0.42 | $0.4 | $0.4 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.74 | $1.97 | $1.79 | |
| Total cash flows from operations | -$14.26 | -$16.69 | -$11.91 | |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.02 | -$0.01 | |
| Investments | $12.97 | $20.21 | -$48.51 | |
| Total cash flows from investing | $33.3 | $12.82 | $20.19 | -$48.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.36 | $0.23 | $0.03 | |
| Net borrowings | $30 | |||
| Total cash flows from financing | $0.62 | $0.36 | $0.23 | $30.03 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$12.02 | -$1.08 | $3.73 | -$30.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$52.34 | -$54.17 | $122.83 | -$81.04 |
| Operating activities | ||||
| Depreciation | $1.6 | $1.38 | $0.24 | $0.31 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.29 | $6.56 | $5.05 | $7.53 |
| Total cash flows from operations | -$45.78 | -$55.23 | $118.61 | -$51.58 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$1.22 | -$0.18 | -$0.13 |
| Investments | -$2.44 | -$86.46 | -$1.63 | $35.04 |
| Total cash flows from investing | -$2.58 | -$87.88 | -$1.82 | $34.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.54 | $0.18 | $0.9 | $47.24 |
| Net borrowings | $30 | |||
| Total cash flows from financing | $30.54 | $0.18 | $0.9 | $47.07 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$17.83 | -$142.93 | $117.69 | $30.14 |
News
Fundamentals
| Market cap | $21.37M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 71.01M |
| Revenue | $631.56K |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$32.50M |
| Revenue Q/Q | 58.76% |
| Revenue Y/Y | 113.07% |
| P/E ratio | -0.66 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 33.84 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.03 |
| EPS | -$0.46 |
|---|---|
| ROA | -26.19% |
| ROE | N/A |
| Debt/Equity | 0.64 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.66 |
| Quick ratio | N/A |